Key result
TandemHeart bridging in post-MI VSD is associated with ~83% 30-day survival.
Why the study?
Post-myocardial infarction ventricular septal defect carries high peri-procedural mortality despite catheter-based therapies, prompting evaluation of bridging percutaneous left ventricular mechanical circulatory support using the TandemHeart device.
Does bridging percutaneous left ventricular mechanical circulatory support using TandemHeart improve survival in patients with post-myocardial infarction ventricular septal defect?
Observational (n=23)
Does bridging percutaneous left ventricular mechanical circulatory support using TandemHeart improve survival in patients with post-myocardial infarction ventricular septal defect?
Bridging with TandemHeart mechanical circulatory support in post-MI VSD patients allows for delayed closure and is associated with high 30-day and 6-month survival rates.
Answers are grounded in this paper and cite their sources.
TandemHeart bridging may facilitate delayed closure with favorable survival in post-MI VSD; hypothesis-generating and requires prospective confirmation before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Loyalka et al. (2020) conducted an observational in post-myocardial infarction (MI) ventricular septal defect (VSD) (n=23). TandemHeart ventricular assist device was evaluated on 30-day survival. Bridging percutaneous left ventricular mechanical circulatory support using the TandemHeart device in patients with post-MI VSD resulted in overall 30-day and 6-month survival rates of 83% and 70%.
Synapse has enriched 10 related papers. Consider them for comparative context: